BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11835343)

  • 1. Coagulation changes in individuals with sickle cell trait.
    Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Schlegel R; Williamson P
    Am J Hematol; 2002 Feb; 69(2):89-94. PubMed ID: 11835343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
    Gupta S; Carmona R; Malvar J; Young G
    Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease.
    Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Zuckerman L; Schlegel R; Williamson P
    J Lab Clin Med; 1999 Oct; 134(4):352-62. PubMed ID: 10521081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procoagulant activity in patients with sickle cell trait.
    Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation activation in sickle cell trait: an exploratory study.
    Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
    Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilia in sickle cell disease: the red cell connection.
    Setty BN; Rao AK; Stuart MJ
    Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
    Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
    Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
    Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
    J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
    Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
    Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation.
    Helley D; Girot R; Guillin MC; Bezeaud A
    Br J Haematol; 1997 Nov; 99(2):268-72. PubMed ID: 9375737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolysis activation after single-incision versus standard laparoscopic cholecystectomy: a single-center prospective case-controlled pilot study.
    Zezos P; Christoforidou A; Kouklakis G; Tsalikidis C; Dimakis C; Laftsidis P; Virgiliou A; Simopoulos C; Pitiakoudis M
    Surg Innov; 2014 Feb; 21(1):22-31. PubMed ID: 23575915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of warfarin on markers of hypercoagulability in patients with heart failure.
    Jafri SM; Mammen EF; Masura J; Goldstein S
    Am Heart J; 1997 Jul; 134(1):27-36. PubMed ID: 9266780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer.
    Kohli M; Fink LM; Spencer HJ; Zent CS
    Blood Coagul Fibrinolysis; 2002 Jan; 13(1):1-5. PubMed ID: 11994561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
    Leroy-Matheron C; Gouault-Heilmann M
    Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
    Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
    Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
    Arkel YS; Paidas MJ; Ku DH
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.